These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Evaluation of ACTH and corticosteroid therapy in multiple sclerosis]. Hamel-Puskarić N; Arko K; Dupelj M; Novak Z; Barac B; Czukor M Neuropsihijatrija; 1969; 17(1):51-70. PubMed ID: 4191305 [No Abstract] [Full Text] [Related]
4. [Diagnostic value of cerebrospinal fluid analysis in myelopathies]. Gårde A; Kjellin K Nord Med; 1971 May; 85(21):674-5. PubMed ID: 5581422 [No Abstract] [Full Text] [Related]
5. [Diagnostic value of cerebrospinal fluid study in multiple sclerosis]. Schädlich HJ Fortschr Neurol Psychiatr; 1990 Jul; 58(7):247-51. PubMed ID: 2202622 [TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis. Davis FA; Stefoski D Arch Dermatol; 1983 Feb; 119(2):178-81. PubMed ID: 6297410 [No Abstract] [Full Text] [Related]
7. [Is there a characteristic cerebrospinal fluid cell picture in multiple sclerosis? The significance of large pyronine-staining round cells in the cerebrospinal fluid]. Schlote W; Roos W Nervenarzt; 1974 Nov; 45(11):576-87. PubMed ID: 4141753 [No Abstract] [Full Text] [Related]
8. [Clinical picture, cerebrospinal fluid findings, and pathological anatomy of subacute demyelinating encephalitis ("mixed form" of multiple, diffuse and concentric sclerosis)]. Jellinger K; Schnaberth G; Traugott U; Turnheim M Nervenarzt; 1976 Feb; 47(2):118-23. PubMed ID: 56720 [No Abstract] [Full Text] [Related]
9. [Comparative value of visual evoked potentials with the study of cerebrospinal fluid in the diagnosis of multiple sclerosis--apropos of 43 cases]. Dalens H; Devoize JL; Sole P Bull Soc Ophtalmol Fr; 1983 May; 83(5):725-6, 729. PubMed ID: 6200247 [No Abstract] [Full Text] [Related]
10. [The behavior of serum immunoglobulins in multiple sclerosis during anti-inflammatory therapy]. Paltrinieri E; Giovannucci M Acta Neurol (Napoli); 1969; 24(4):613-25. PubMed ID: 4101181 [No Abstract] [Full Text] [Related]
11. Treatment and prevention of myelin disorders: multiple sclerosis. Abramsky O Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():489-92. PubMed ID: 6326915 [No Abstract] [Full Text] [Related]
13. History, facts, problems and clinical aspects of multiple sclerosis. Bauer HJ Int Arch Allergy Appl Immunol; 1969; 36():Suppl:3-21. PubMed ID: 5373037 [No Abstract] [Full Text] [Related]
14. [Therapy of multiple sclerosis]. Arasa F Folia Clin Int (Barc); 1969 Jan; 19(1):7-23. PubMed ID: 4308450 [No Abstract] [Full Text] [Related]
15. [Diagnostic importance of cerebrospinal fluid syndromes with examples of cases]. Krause WR; Eckert R Z Arztl Fortbild (Jena); 1984; 78(5):195-7. PubMed ID: 6719952 [No Abstract] [Full Text] [Related]
16. Management of multiple sclerosis. Poser CM Compr Ther; 1981 Apr; 7(4):53-9. PubMed ID: 6263543 [No Abstract] [Full Text] [Related]
17. [Results of clinical investigation in patients with multiple sclerosis (author's transl)]. Ladurner G; Schraml H; Sager WD; Flooh E; Lepuschütz H; Lechner H Nervenarzt; 1981 Jun; 52(6):340-3. PubMed ID: 7266697 [No Abstract] [Full Text] [Related]
18. [Cyclophosphamide in the therapy of multiple sclerosis]. Salvatores U; Majeron M; Mascetti A Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775 [No Abstract] [Full Text] [Related]
19. [Correlation between the cytology and the protein pattern of the cerebrospinal fluid and certain clinical parameters in multiple sclerosis. Analysis of 185 cases]. Stenuit J Acta Neurol Belg; 1972; 72(4):265-78. PubMed ID: 4120108 [No Abstract] [Full Text] [Related]
20. [The immune status as an indicator for parameter-dependent therapy of multiple sclerosis?]. Kuppe G; Schmidt RM; Ludewig R Nervenarzt; 1989 Sep; 60(9):549-52. PubMed ID: 2812159 [No Abstract] [Full Text] [Related] [Next] [New Search]